Trading Halt Request

171201_Trading Halt Request

Recent Articles

Olivia Newton-John Cancer Research Institute Update
September 10, 2018
Preliminary Final Statements to the ASX
September 3, 2018
Hope on the horizon for chemo alternative
August 17, 2018
Top 20 Shareholders August 2018
August 17, 2018

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

PharmAust @PharmAust·

11 Sep

Researchers at the Olivia Newton-John Cancer Research Institute in Melbourne have independently confirmed the ability of Pharmaust’s anti-cancer drug, Monepantel, to impact cancer cells. https://t.co/S8cJFYfHcP

Reply on Twitter Retweet on Twitter3 Like on Twitter1 Twitter

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top